Watch the latest episode of focusIR Fireside Chats: Why Edinburgh Investment Trust Is Backing Turnaround Stocks for 2026 Growth. Viewhere

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksDirecta Plus Regulatory News (DCTA)

  • This share is currently suspended. It was suspended at a price of 6.75
  • There is currently no data for DCTA

Covid-19 Update

23 Mar 2020 07:00

RNS Number : 1214H
Directa Plus PLC
23 March 2020
 

23 March 2020

 

THE INFORMATION CONTAINED WITHIN THIS ANNOUNCEMENT IS DEEMED BY THE COMPANY TO CONSTITUTE INSIDE INFORMATION AS STIPULATED UNDER THE EU MARKET ABUSE REGULATION (596/2014). UPON THE PUBLICATION OF THE ANNOUNCEMENT VIA A REGULATORY INFORMATION SERVICE, THIS INFORMATION IS CONSIDERED TO BE IN THE PUBLIC DOMAIN.

 

Directa Plus plc

("Directa Plus", "the Group" or the "Company")

 

COVID-19 Update

 

Directa Plus (AIM: DCTA), a leading producer and supplier of graphene nanoplatelets based products for use in consumer and industrial markets, notes the announcement by the Italian Government to close down all productive activity that is not "strictly necessary, crucial, indispensable, to guarantee us essential goods and services." Directa Plus is classified as a chemical company in Italy and as such is exempt from any restrictions and will continue to operate its core business.

 

The Company continues to actively support the Italian authorities, at both local and national level, in their struggle to combat the Covid-19 emergency by making available its technologies. Directa Plus's graphene is non-toxic and its bacteriostatic properties could be used in the production of medical devices such as masks, gloves and gowns to ensure better prevention properties for the spread of the virus.

 

Commenting, Giulio Cesareo, CEO and Founder, said, "Medical equipment enhanced by graphene could mean a safer working environment for the health workers and all citizens. In the health industry graphene is well known for antibacterial and filtering properties and we will continue to develop protective devices using our non-toxic G+ graphene to benefit our fellow citizens during this emergency."

 

This announcement has been approved by Giulio Cesareo, Chief Executive, on behalf of the Company.

 

For further information please visit http://www.directa-plus.com/ or contact:

 

Directa Plus plc

+39 02 36714458

Giulio Cesareo, CEO

 

Marco Ferrari, CFO

 

 

 

Cantor Fitzgerald Europe (Nominated Adviser and Joint Broker)

+44 20 7894 7000

Rick Thompson, Philip Davies, Will Goode (Corporate Finance)

 

Caspar Shand Kydd (Sales)

 

 

 

N+1 Singer (Joint Broker)

+44 20 7496 3069

Mark Taylor, Lauren Kettle

 

 

 

Tavistock (Financial PR and IR)

+44 20 7920 3150

Simon Hudson, Edward Lee

 

 

About Directa Plus

Our focus is principally on the two sectors in which we have strong commercial advantage through developed and launched products and a technological lead: environmental (based on our Grafysorber® product) and textiles (based on our G+ products). In addition, we will continue to pursue opportunities in elastomers and composites (including tyres and asphalt), also using our G+ products. All our products are hypoallergenic, non-toxic and sustainably produced.

 

-ends-

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
END
 
 
UPDUUAARROUOUUR
Date   Source Headline
1st Jun 20187:00 amRNSTransfer in Significant Shareholding
25th May 20187:00 amRNSNotice of AGM
14th May 20187:00 amRNSExclusive Collaboration Agreement with Arvind
2nd May 20181:06 pmRNSDirector Share Purchase
1st May 201810:56 amRNSDirector Share Purchase
30th Apr 20187:00 amRNSAgreement with Global Leader in Luxury Accessories
26th Apr 20187:00 amRNSDirectorate Change
26th Apr 20187:00 amRNSFinal Results
23rd Apr 20187:00 amRNSStrategic Collaboration with Marangoni Group
9th Apr 20188:25 amRNSSuccessful Grafysorber® field test with OMV Petrom
21st Mar 20187:00 amRNSSartec agreement to commercialise Grafysorber®
19th Feb 20187:00 amRNSPatent for G+ elastomeric composition for tyres
6th Feb 20187:07 amRNSColmar and Eurojersey launch new G+ collections
24th Jan 20187:00 amRNSUS patent for graphene flame-retardant composition
15th Jan 20187:00 amRNSPre-Close Trading Update
21st Dec 20177:00 amRNSOrder from Vittoria
14th Dec 20177:00 amRNSCollaboration with GSP SA on Grafysorber®
23rd Nov 20177:00 amRNSDirecta Plus and Iterchimica develop Eco Pave
14th Nov 20177:00 amRNSG+ textiles certified as 'non-irritating'
11th Oct 201712:27 pmRNSDirector/PDMR Shareholding
10th Oct 20171:13 pmRNSPDMR Shareholding
28th Sep 20177:01 amRNSContract with Alfredo Grassi to supply G+ graphene
28th Sep 20177:00 amRNSInterim Results
21st Aug 20177:00 amRNSAppointment of Luca Provolo as Head of Sales
3rd Aug 20174:35 pmRNSPrice Monitoring Extension
22nd Jun 20177:00 amRNSDirecta Plus collaboration with Alfredo Grassi
7th Jun 20173:54 pmRNSResult of AGM
7th Jun 20172:22 pmRNSAGM Statement
25th May 201710:46 amRNSDirector Dealing
12th May 20177:00 amRNSAnnual Report Posting, AGM Notice & Options Grant
9th May 201711:05 amRNSDirector/PDMR Shareholding
5th May 20177:00 amRNSDirector Dealing
4th May 201710:47 amRNSDealing by Proposed Director
4th May 20177:00 amRNSDirector/PDMR Shareholding
28th Apr 201711:00 amRNSPrice Monitoring Extension
28th Apr 20179:50 amRNSDirectorate Changes
28th Apr 20177:00 amRNSFinal Results
20th Feb 20177:00 amRNSGrant Award for Textiles Project
2nd Dec 20167:00 amRNSCustomer Announcement
22nd Nov 20167:00 amRNSDirecta Plus Achieves ISO 14001:2015 Certification
14th Nov 20167:00 amRNSAcquisition and Directa Textile Solutions launch
18th Oct 20167:01 amRNSFurther two patents granted
18th Oct 20167:00 amRNSCustomer announcement
21st Sep 20167:00 amRNSInterim Results
15th Sep 201610:30 amRNSDirector Declaration
18th Aug 20167:00 amRNSChange of Registered Address
14th Jul 20164:04 pmRNSHolding(s) in Company
7th Jun 20164:35 pmRNSPrice Monitoring Extension
2nd Jun 20164:40 pmRNSSecond Price Monitoring Extn
2nd Jun 20164:35 pmRNSPrice Monitoring Extension

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.